JNGLX
Price
$67.24
Change
+$0.25 (+0.37%)
Updated
Jul 25 closing price
Net Assets
4.4B
LHCAX
Price
$18.36
Change
+$0.06 (+0.33%)
Updated
Jul 25 closing price
Net Assets
7.3M
Interact to see
Advertisement

JNGLX vs LHCAX

Header iconJNGLX vs LHCAX Comparison
Open Charts JNGLX vs LHCAXBanner chart's image
Janus Henderson Global Life Sciences D
Price$67.24
Change+$0.25 (+0.37%)
VolumeN/A
Net Assets4.4B
Lord Abbett Health Care A
Price$18.36
Change+$0.06 (+0.33%)
VolumeN/A
Net Assets7.3M
JNGLX vs LHCAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LHCAX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LHCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.4B vs. LHCAX (7.3M). JNGLX pays higher dividends than LHCAX: JNGLX (0.36) vs LHCAX (0.33). JNGLX was incepted earlier than LHCAX: JNGLX (27 years) vs LHCAX (6 years). LHCAX (3.34) is less costly to investors than JNGLX (0.80). LHCAX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCAX has a lower initial minimum investment than JNGLX: LHCAX (1500) vs JNGLX (2500). LHCAX annual gain was more profitable for investors over the last year : -6.57 vs. JNGLX (-14.11). JNGLX return over 5 years is better than : 5.37 vs. LHCAX (2.53).
JNGLXLHCAXJNGLX / LHCAX
Total Expense Ratio0.801.0378%
Annual Report Gross Expense Ratio0.803.3424%
Fund Existence27 years6 years-
Gain YTD-0.957-4.17523%
Front LoadN/A6%-
Min. Initial Investment25001500167%
Min. Initial Investment IRAN/AN/A-
Net Assets4.4B7.3M60,318%
Annual Yield % from dividends0.360.33109%
Returns for 1 year-14.11-6.57215%
Returns for 3 years9.247.63121%
Returns for 5 years5.372.53212%
Returns for 10 years7.20N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BAFMX18.540.20
+1.09%
Brown Advisory Mid-Cap Growth Instl
TRMNX22.800.19
+0.84%
T. Rowe Price Mid-Cap Index
MSGFX33.610.18
+0.54%
Morgan Stanley Inst Global Franchise C
JGTUX44.120.22
+0.50%
JPMorgan Growth Advantage R4
GHTMX15.38-0.02
-0.13%
Goldman Sachs International T/M Eq Instl